Clinical Trial Update: Safety and Efficacy of BRM421 for Dry Eye Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting safety and efficacy data for BRM421 in Dry Eye Syndrome. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• BRM421

Snippet

Sponsor: BRIM Biotechnology Inc. | Conditions: Dry Eye Syndrome | Phase 2 | Status: COMPLETED